arrow
J

Julien Dairou

université parís cité
H指数:34
被引数:4,333

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhancing virtual screening of cystathionine β-synthase inhibitors: benchmarking target-specific machine-learning scoring functions against state-of-the-art AI docking and co-folding approaches

增强胱硫醚β-合成酶抑制剂的虚拟筛选:将目标特异性机器学习评分函数与最先进的AI对接和共折叠方法进行基准测试

2026-07-180
OA
Mapping the Brain Interaction Network of the Dual-Specificity; Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Targeted by Leucettinib-21 Using Affinity Chromatography

利用亲和层析技术研究被Leucettinib-21靶向的双特异性酪氨酸磷酸化调控激酶1A(DYRK1A)的大脑相互作用网络图谱

2026-04-150
PRE
Molecular and cellular effects of hydroxy-1,4 naphthoquinones used in dermatological and cosmetic applications on human protein tyrosine phosphatase PTP1B in human keratinocytes

羟基-1,4-萘醌类化合物在皮肤病学和化妆品应用中对人角化细胞中蛋白酪氨酸磷酸酶PTP1B的分子和细胞效应

2025-05-230
PRE
Harnessing intestinal tryptophan catabolism to relieve atherosclerosis in mice
2024-07-290
OAAI
PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis
2024-06-062
OAAI
MFSD1 with its accessory subunit GLMP functions as a general dipeptide uniporter in lysosomes
2024-06-050
OAAI
Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer's Disease Drug Candidate

唐氏综合症和阿尔茨海默氏病候选药物Leucettinib-21的化学,生化,细胞和生理特征

2023-12-057
OA
PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption
2022-12-0913
OAAI